1604610

Risedronat

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): Risedronsäure Mononatriumsalz Hemi(pentahydrat)
• Empirische Formel (Hill-System): C₇H₁₀NNaO₇P₂ · 2.5H₂O
• CAS-Nummer: 329003-65-8
• Molekulargewicht: 350.13
• MDL-Nummer: MFCD01706268
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: risedronate
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• SMILES String: OP(C(P(O)([O-])=O)(O)CC1=CC=CN=C1)(O)=O.[Na+]
• InChI: 1S/2C7H11NO7P2.2Na.5H2O/c2*9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;;;;;;;/h2*1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);;;5*1H2/q;;2*+1;;;;;/p-2
• InChIKey: HYFDYHPNTXOPPO-UHFFFAOYSA-L

Beschreibung

Allgemeine Beschreibung

Risedronate sodium is a member of the pyridinyl class of bisphosphonates. It is mostly used as an antiresorptive agent. It can be used in treating and preventing postmenopausal and glucocorticoid-induced osteoporosis.

Anwendung

Risedronate sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Risedronate Sodium Tablets
• Risedronate Sodium Delayed-Release Tablets

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08,GHS07
• Signalwort: Warning
• H-Sätze: H302,H319,H361,H371
• P-Sätze: P202 - P260 - P264 - P301 + P312 - P305 + P351 + P338 - P308 + P311
• Gefahreneinstufungen: Acute Tox. 4 Oral - Eye Irrit. 2 - Repr. 2 - STOT SE 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable